Endotech Revenue and Competitors
Estimated Revenue & Valuation
- Endotech's estimated annual revenue is currently $7.4M per year.
- Endotech's estimated revenue per employee is $117,000
Employee Data
- Endotech has 63 Employees.
- Endotech grew their employee count by 7% last year.
Endotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $42.9M | 300 | 13% | N/A | N/A |
#2 | $0.1M | 7 | 0% | $4.3M | N/A |
#3 | $12.2M | 94 | 24% | N/A | N/A |
#4 | $13.8M | 106 | N/A | $8M | N/A |
#5 | $57.8M | 350 | -2% | $583M | N/A |
#6 | $6.8M | 60 | -10% | $39.5M | N/A |
#7 | $2.4M | 26 | N/A | N/A | N/A |
#8 | $2.6M | 29 | N/A | N/A | N/A |
#9 | $0.9M | 12 | N/A | N/A | N/A |
#10 | $4.2M | 40 | N/A | N/A | N/A |
What Is Endotech?
EndoTech's market-proven Artificial Intelligence and Machine Learning is the first cohesive and actionable set of crypto AI/ML techniques to service the blockchain investment market. EndoTech solutions are designed to scale with the increasing size of different crypto assets available for trading. As the number of coins continues to grow so will our ability to filter the noise of the market activity and provide valuable content on what is moving, happening and developing. Contact support@endotech.io to distribute our content legally #crypto $btc $eth #algotrading
keywords:N/A
N/A
Total Funding
63
Number of Employees
$7.4M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Endotech News
Endotech, founded by Dr Anna Becker and Dmitry Gooshchin, is looking to streamline the nuances around trading and getting involved in...
Founder at Salesclass, partner at EndoTech.io. Proven commercial leader for FinTech. Born into Fortune 500, now building tech companies.
Other Companies in Ramat Gan
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.2M | 63 | N/A | N/A |
#2 | $9.1M | 63 | -7% | N/A |
#3 | $7.7M | 66 | -25% | N/A |
#4 | N/A | 70 | 250% | N/A |
#5 | N/A | 74 | -5% | N/A |